Ceftolozane Antibiotic Compositions
Patent No. EP2893929 (titled "Ceftolozane Antibiotic Compositions") was filed by Calixa Therapeutics on Mar 14, 2014. The application was issued on Apr 16, 2025.
Patent Summary
Pharmaceutical compositions comprising ceftolozane and sodium chloride, wherein the sodium chloride is present in an amount sufficient to stabilize the ceftolozane. The compositions have fewer additional compounds and are more chemically stable, and can therefore be stored for longer periods of time.
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP2893929
- Application Number
- EP14199792A
- Filing Date
- Mar 14, 2014
- Status
- Granted And Under Opposition
- Mar 14, 2025
- Publication Date
- Apr 16, 2025
- External Links
- Slate, Register , Google Patents